ByHeart-Infant-Formula-Class-Action-Filed-Over-Botulism-Contamination-Risks

concerns among parents and public health officials continue to rise after a new class action lawsuit was filed against ByHeart Inc., alleging that the company’s infant formula products were contaminated with Clostridium botulinum, the bacteria responsible for infant botulism. This lawsuit, brought by Plaintiff Monica Valenzuela, argues that ByHeart failed to disclose contamination risks on its packaging, misleading thousands of families who trusted the brand’s ByHeart Whole Nutrition Infant Formula and Whole Nutrition Infant Formula product lines. According to the complaint, ByHeart’s contaminated baby formula may expose infants to severe bacterial infection risks, including infantile botulism, a rare but potentially fatal illness. Families affected by such incidents may seek guidance from a personal injury lawyer to understand their legal options. The lawsuit was filed in New York federal court, where Valenzuela seeks to represent a nationwide class of consumers affected by the contamination.

Allegations Against ByHeart and the Botulism Outbreak Concerns

Valenzuela alleges that ByHeart continued to market its ByHeart formula without disclosing that multiple batches of formula and single-serve sticks may have been contaminated with Clostridium botulinum. The fear of a potential botulism outbreak, or a broader infant botulism outbreak, prompted parents and public health agencies to demand clearer answers.

The lawsuit emphasizes:

“Infant botulism is a rare but potentially fatal illness that poses a serious threat to the health of infants.”

This aligns with warnings issued in previous Food and Drug Administration and Centers for Disease Control and Prevention updates regarding botulinum neurotoxin risks in food products consumed by infants.

Valenzuela further argues that ByHeart’s handling of the issue amounts to unjust enrichment, negligence, and violations of consumer protection laws.

ByHeart’s Nationwide Formula Recall

On November 8, ByHeart initiated a limited formula recall. Only days later, on November 11, the recall expanded to include all ByHeart infant formula, affecting cans, single-serve sticks, and the single-serve Anywhere Pack versions.

The company’s expansion followed findings from the U.S. Food and Drug Administration, which reportedly confirmed two additional cases of infant botulism tied to ByHeart formula. These cases prompted a deeper outbreak investigation, which included testing unopened cans, analyzing lot numbers, and reviewing lot codes to determine contamination sources.

However, the lawsuit argues that the recalled product notice was too narrow, too slow, and reached far fewer parents than it should have. Public health agencies, including the California Department of Public Health and other federal and state health officials, emphasized that families needed more direct guidance to discontinue use of affected products.

Public Health Impact: Infant Hospitalizations and Adverse Events

Infants exposed to contaminated formula may experience:

  • Muscle weakness
  • Feeding difficulties
  • Need for feeding tube assistance
  • Possible need for air ambulance transfer to specialized hospitals
  • IV lines or blood plasma treatment
  • Speech and feeding therapy

Some cases may involve involvement from the Infant Botulism Treatment and Prevention Program, which tracks and supports responses to infant botulism cases.

Medical experts caution that Clostridium botulinum contamination may not only cause hospitalization but, in rare cases, may lead to wrongful death. These events become part of an adverse event reporting system monitored through Voluntary MedWatch form submissions.

A Growing History of Formula Lawsuits

This ByHeart controversy echoes previous issues seen in the formula industry.

Manufacturers such as Abbott Laboratories, Enfamil, and Similac have faced recall lawsuits related to:

  • Cronobacter sakazakii contamination
  • Cronobacter infections
  • necrotizing enterocolitis in premature infants
  • Batches of formula that failed safety and sanitation standards

The rising number of claims has contributed to ongoing multidistrict litigation, including active ByHeart Formula Recall Lawsuit cases, NEC litigation, and other formula lawsuit actions nationwide.

Parents who purchased ByHeart products on online marketplaces, retail stores, or wholesale warehouses may qualify for compensation if their children were affected.

Valenzuela seeks:

  • Declaratory and injunctive relief
  • Monetary, statutory, compensatory, and punitive damages
  • Coverage for medical expenses
  • Recognition that ByHeart’s recall failed to adequately protect families

The lawsuit argues that class action litigation is necessary because individual parents may lack the resources or medical records needed to pursue personal injury claims independently.

The suit highlights issues such as:

  • Exposure to contaminated product lines
  • Concerns about safety and sanitation violations during production
  • Potential failures in ByHeart’s surveillance system
  • Inadequate public advisory notifications
  • Lack of a proper support hotline for families

Broader Impact on the Baby Formula Industry

This case comes at a time when the baby formula industry is already under scrutiny due to:

  • Past contamination incidents
  • baby formula shortage concerns
  • Rising pressure from public health officials
  • Increased lab testing and laboratory analysis
  • Demands for clearer formula test results

American authorities and the Centre for Food Safety have emphasized the need for stronger oversight and earlier detection of contamination in all baby formula production.

How Families May Be Affected

Families affected by the ByHeart recall may face:

  • Emotional distress
  • Medical costs
  • Disruptions to feeding routines
  • Concerns about contaminated batches of formula
  • Need for long-term therapies due to infant botulism complications

Some families, such as the widely discussed Kentucky family, experienced severe outcomes requiring intensive care and long-term treatment.

Affected parents may pursue:

  • Personal injury claims
  • Product liability lawsuits
  • Participation in recall lawsuits
  • Claims for settlements and compensation on a contingency-fee basis

These claims may be pursued individually or through class action structures.

About TED Law

At Ted Law Firm, we support families who have been impacted by contaminated formula, unsafe consumer products, and corporate negligence. We serve families across Aiken, Anderson, Charleston, Columbia, Greenville, Myrtle Beach, North Augusta and Orangeburg.Our legal team handles complex product liability cases, including infant formula contamination, botulism risk claims, and recall-related injuries. We help parents understand their rights and explore paths for justice, accountability, and recovery. If your child used a recalled formula product and suffered harm, TED Law is here to provide clear guidance and dedicated legal representation.

Back to Blog